Invesco’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Invesco’s Portfolio HELP Stock Details HELP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$153K	Buy	+23,130	New	+$116K	﹤0.01%	3662

Other funds holding HELP

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

Invesco's HELP Position: Q2 2026 in Review

Invesco opened a new position in Helus Pharma Inc. Common Stock (HELP) in Q2 2026: 23,130 shares worth $153K. The stake represents ﹤0.01% of the portfolio and ranks #3662 among its holdings.

99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

Invesco held 23,130 shares of Helus Pharma Inc. Common Stock worth $153K as of Q2 2026.
Helus Pharma Inc. Common Stock was a new Invesco position in Q2 2026.
Helus Pharma Inc. Common Stock made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3662 holding.
99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.